KANTARO Trademark

Trademark Overview


On Monday, May 18, 2020, a trademark application was filed for KANTARO with the United States Patent and Trademark Office. The USPTO has given the KANTARO trademark a serial number of 88922039. The federal status of this trademark filing is REGISTERED as of Tuesday, March 8, 2022. This trademark is owned by Kantaro Biosciences LLC. The KANTARO trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic testing and analysis equipment and apparatus for performing serological, molecular polymerase chain reaction (PCR), antigen and antibody tests, namely, medical diagnostic apparatus for testing for infections, viruses, disorders and diseases; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens and tissue; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens and tissue; Apparatus for analysis of biological materials for medical purposes; Medical apparatus and instruments for diagnostic analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics for detecting, measuring and analyzing DNA, RNA, antibo...
kantaro

General Information


Serial Number88922039
Word MarkKANTARO
Filing DateMonday, May 18, 2020
Status700 - REGISTERED
Status DateTuesday, March 8, 2022
Registration Number6667510
Registration DateTuesday, March 8, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2021

Trademark Statements


Goods and ServicesMedical diagnostic testing and analysis equipment and apparatus for performing serological, molecular polymerase chain reaction (PCR), antigen and antibody tests, namely, medical diagnostic apparatus for testing for infections, viruses, disorders and diseases; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens and tissue; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens and tissue; Apparatus for analysis of biological materials for medical purposes; Medical apparatus and instruments for diagnostic analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics for detecting, measuring and analyzing DNA, RNA, antibodies, enzymes, antigens, viral, infectious, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases, viruses and infections for medical and clinical purposes; Medical apparatus, instruments and devices for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Kits for testing for the presence of antibodies in blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue for medical purposes; Medical diagnostic apparatus and devices for detecting SARS-CoV-2 and COVID-19; Diagnostic apparatus for detecting infection; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Medical bags, pouches and containers for the collection and preservation and transport of blood, biofluids, bodily fluids, biological and cellular samples and specimens and tissue obtained from humans

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, June 3, 2020
Primary Code010
First Use Anywhere DateFriday, August 14, 2020
First Use In Commerce DateFriday, August 28, 2020

Trademark Owner History


Party NameKantaro Biosciences LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10036

Party NameKantaro Biosciences LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10036

Party NameKantaro Biosciences LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10036

Trademark Events


Event DateEvent Description
Tuesday, March 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, February 1, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 31, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 28, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 13, 2022USE AMENDMENT FILED
Friday, January 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 13, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, July 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 18, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 18, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 13, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, April 13, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 13, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, April 13, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, April 1, 2021ASSIGNED TO EXAMINER
Monday, March 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 26, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, November 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, November 8, 2020NON-FINAL ACTION E-MAILED
Sunday, November 8, 2020NON-FINAL ACTION WRITTEN
Saturday, November 7, 2020ASSIGNED TO EXAMINER
Wednesday, June 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 21, 2020NEW APPLICATION ENTERED IN TRAM